The case for addressing primary resistance mutations to non-nucleoside reverse transcriptase inhibitors to treat children born from mothers living with HIV in sub-Saharan Africa.

J Int AIDS Soc · 2014 · PMC3895257 · PMID 24439027

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Despite the small sample size of the present series, these results suggest that DRM prevalence may be significant in the paediatric Senegalese population living with HIV and younger than 18 months.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.